Dhingra Kapil 4

What Happened

• Kapil Dhingra, a director of Replimune Group, was granted an award (derivative option) covering 44,500 shares on April 1, 2026. The Form 4 shows an acquisition at $0.00 (derivative instrument), so there was no cash purchase or sale reported at grant. Per the filing footnote, the shares underlying this option vest entirely on April 1, 2027.

Key Details

• Transaction date: 2026-04-01
• Transaction type/code: Grant/Award (A) — derivative option
• Shares/units: 44,500 underlying shares
• Price reported: $0.00 (grant of a derivative instrument)
• Vesting: Entire award vests on April 1, 2027 (footnote F1)
• Shares owned after transaction: Not disclosed on this Form 4
• Timeliness: Form 4 was filed late; filer cites an inadvertent administrative error (timeliness flag L)

Context

• This was a compensation-related option grant, not a market purchase or sale — no immediate cash exchanged and no immediate change in public float. Such grants are commonly used to compensate and retain directors; they do not by themselves indicate buying or selling sentiment. The late filing reduces prompt public transparency but the reason provided was administrative.